Christopher M Starr - Net Worth and Insider Trading
Christopher M Starr Net Worth
The estimated net worth of Christopher M Starr is at least $26 Million dollars as of 2024-11-13. Christopher M Starr is the SVP, Chief Scientific Officer of Biomarin Pharmaceutical Inc and owns about 295,176 shares of Biomarin Pharmaceutical Inc (BMRN) stock worth over $20 Million. Christopher M Starr is also the Director of Raptor Pharmaceutical Corp and owns about 701,044 shares of Raptor Pharmaceutical Corp (RPTP) stock worth over $6 Million. Details can be seen in Christopher M Starr's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher M Starr has not made any transactions after 2015-03-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher M Starr
Christopher M Starr Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher M Starr owns 3 companies in total, including Monopar Therapeutics Inc (MNPR) , Raptor Pharmaceutical Corp (RPTP) , and Biomarin Pharmaceutical Inc (BMRN) .
Click here to see the complete history of Christopher M Starr’s form 4 insider trades.
Insider Ownership Summary of Christopher M Starr
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MNPR | Monopar Therapeutics Inc | 2022-12-31 | director |
| RPTP | Raptor Pharmaceutical Corp | 2016-10-24 | director |
| BMRN | Biomarin Pharmaceutical Inc | 2005-12-01 | Sr. VP & Scientific Operations |
Christopher M Starr Latest Holdings Summary
Christopher M Starr currently owns a total of 2 stocks. Among these stocks, Christopher M Starr owns 295,176 shares of Biomarin Pharmaceutical Inc (BMRN) as of December 1, 2005, with a value of $20 Million and a weighting of 75.57%. Christopher M Starr also owns 701,044 shares of Raptor Pharmaceutical Corp (RPTP) as of March 23, 2015, with a value of $6 Million and a weighting of 24.43%.
Latest Holdings of Christopher M Starr
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BMRN | Biomarin Pharmaceutical Inc | 2005-12-01 | 295,176 | 66.12 | 19,517,037 |
| RPTP | Raptor Pharmaceutical Corp | 2015-03-23 | 701,044 | 9.00 | 6,309,396 |
Holding Weightings of Christopher M Starr
Christopher M Starr Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher M Starr has made a total of 0 transactions in Biomarin Pharmaceutical Inc (BMRN) over the past 5 years. The most-recent trade in Biomarin Pharmaceutical Inc is the sale of 10,571 shares on December 1, 2005, which brought Christopher M Starr around $105,710.
According to the SEC Form 4 filings, Christopher M Starr has made a total of 0 transactions in Raptor Pharmaceutical Corp (RPTP) over the past 5 years. The most-recent trade in Raptor Pharmaceutical Corp is the sale of 20,033 shares on March 23, 2015, which brought Christopher M Starr around $232,783.
Insider Trading History of Christopher M Starr
- 1
Christopher M Starr Trading Performance
Christopher M Starr Ownership Network
Ownership Network List of Christopher M Starr
Ownership Network Relation of Christopher M Starr
Christopher M Starr Owned Company Details
What does Monopar Therapeutics Inc do?
Who are the key executives at Monopar Therapeutics Inc?
Christopher M Starr is the director of Monopar Therapeutics Inc. Other key executives at Monopar Therapeutics Inc include Chief Operating Officer Andrew Cittadine , Chief Financial Officer Kim R Tsuchimoto , and director & Chief Executive Officer Chandler Robinson .
Monopar Therapeutics Inc (MNPR) Insider Trades Summary
Over the past 18 months, Christopher M Starr made no insider transaction in Monopar Therapeutics Inc (MNPR). Other recent insider transactions involving Monopar Therapeutics Inc (MNPR) include a net purchase of 128,508 shares made by Andrew Cittadine , and a net purchase of 1,550 shares made by Karthik Radhakrishnan .
In summary, during the past 3 months, insiders sold 0 shares of Monopar Therapeutics Inc (MNPR) in total and bought 1,550 shares, with a net purchase of 1,550 shares. During the past 18 months, 0 shares of Monopar Therapeutics Inc (MNPR) were sold and 27,252 shares were bought by its insiders, resulting in a net purchase of 27,252 shares.
Monopar Therapeutics Inc (MNPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Monopar Therapeutics Inc Insider Transactions
Christopher M Starr Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher M Starr. You might contact Christopher M Starr via mailing address: C/o Monopar Therapeutics Inc, 1000 Skokie Blvd., Suite 350, Wilmette Il 60091.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
